Transurethral balloon dilatation of the prostate and transurethral plasmakinetic resection of the prostate in the treatment of prostatic hyperplasia

ABSTRACT

Background and Objective: With the aggravation of global aging, benign prostate hyperplasia tends to have a higher incidence and has been the most common disease in urinary surgery. It is usually treated by surgery. Our objective was to select an effective treatment scheme, the clinical efficacy and relevant indicators of transurethral balloon dilatation of the prostate [TUDP] and transurethral plasmakinetic resection of the prostate [PKRP] in the treatment of benign prostate hyperplasia were emphatically compared